The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of Acinetobacter baumannii

Marc Gaona, Jordi Corral, Susana Campoy, Jordi Barbé, María Pérez−Varela, Jesús Aranda

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

3 Cites (Scopus)

Resum

Acinetobacter baumannii is a notorious opportunistic pathogen responsible for healthcare-associated infections worldwide. Efflux pumps play crucial roles in mediating antimicrobial resistance, motility, and virulence. In this study, we present the identification and characterization of the new A. baumannii efflux pump SxtP belonging to the MFS superfamily (major facilitator superfamily), along with its associated activator LysR-type transcriptional regulator (LTTR) SxtR, demonstrating their roles in sulfamethoxazole/trimethoprim (also known as co-trimoxazole or SXT) resistance, surface-associated motility and virulence.
Idioma originalAnglès
Número d’articlee00712-24
Nombre de pàgines6
RevistaAntimicrobial Agents and Chemotherapy
Volum68
Número10
Data online anticipada28 d’ag. 2024
DOIs
Estat de la publicacióPublicada - 28 d’ag. 2024

Fingerprint

Navegar pels temes de recerca de 'The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of Acinetobacter baumannii'. Junts formen un fingerprint únic.

Com citar-ho